• 1
    Peleman RR, Gavaler JS, Van Thiel DH, Esquivel C, Gordon R, Iwatsuki S, Starzl TE. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987; 7: 484489.
  • 2
    Baker AL, Jaspan JB, Haines NW, Hatfield GE, Krager PS, Schneider JF. A randomized clinical trial of insulin and glucagon infusion for treat-ment of alcoholic hepatitis: progress report in 50 patients. Gastroenterol-ogy 1981; 80: 14101414.
  • 3
    Okita K, Matsuda S, Hanta T, Yasunaga M, Sanuki K, Takemoto T. Clinical evaluation of glucagon and insulin in therapy for severe acute hepatitis. Gastroenterol Jpn 1987; 22: 607613.
  • 4
    Oka H, Fujiwara K, Okita K, Ishii H, Sakuma A. A multi-centre doubleblind controlled trial of glucagon and insulin therapy for severe acute hepatitis. Gastroenterol Jpn 1989; 24: 332336.
  • 5
    Mourelle M, Rubalcava B. Changes in the insulin and glucagon receptors in the regenerating liver following intoxication with carbon tetrachloride. Biochem Biophys Res Commun 1979; 88: 189198.
  • 6
    Nishiguchi S, Kuroki T, Takeda T, Nakajima S, Shiomi S, Seki S, Matui-Yuasa I, et al. Effects of putrescine on D-galactosamine—induced acute liver failure in rats. Hepatology 1990; 12: 348353.
  • 7
    Michalopoulos GK. Liver regeneration: molecular mechanisrns of growth control. FASEB J 1990; 4: 176187.
  • 8
    Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440443.
  • 9
    Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992; 16: 12271235.
  • 10
    Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993; 18: 14431449.
  • 11
    Francavilla A, DiLeo A, Polimeno L, Gavaler J, Pellicci R, Todo S, Kam I, et al. The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology 1986; 6: 13461351.
  • 12
    Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, et al. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989; 9: 875881.
  • 13
    Tsubouchi H, Kawakami S, Hirono S, Miyazaki H, Kimoto M, Arima T, Sekiyama K, et al. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet 1992; 340: 307.
  • 14
    Francavilla A, Azzarone A, Carrieri G, Cillo U, Van Thiel D, Subbottin V, Starzl TE. Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology 1993; 17: 429433.
  • 15
    Feiig P, Brown WV, Levine RA, Klatskin G. Glucose homeostasis in viral hepatitis. N Engl J Med 1970; 283: 14361440.
  • 16
    Monier D, Wagle SR. Studies on gluconeogenesis in galactosamine induced hepatitis. Proc Soc Exp Biol Med 1971; 136: 377380.
  • 17
    Suzuki H, Tominaga T, Mizuno H, Kouno M, Suzuki M, Kato Y, Sato A, et al. Ethanol and hydrazine sulfate induced chronic hepatic injury in rats: the curative effect of administration of glucogenic amino acids. Alcohol Alcohol 1993; 28: 111117.
  • 18
    Maezano K, Kajiwara K, Mawatari K, Shinkai A, Torii K, Maki T. Alanine protects liver from injury caused by D-galactosamine and CCl4 Hepatology, 1996; 24: 185191.
  • 19
    Uno S, Ito S, Kurono M, Yamaoka Y, Kamiyama Y, Ozawa K. A simple and sensitive assay for blood ketone bodies using highly purified 3-hydro-xybutyrate dehydrogenase. Clin Chim Acta 1987; 168: 253255.
  • 20
    Saibara T, Onishi S, Sone J, Yamamoto N, Shimahara Y, Mori K, Ozawa K, et al. Arterial ketone body ratio as a possible indicator for liver trans-plantation in fulminant hepatic failure. Transplantation 1991; 51: 782786.
  • 21
    Bergmeyer HU, Scheibe P, Wahlefeld AW. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem 1978; 24: 5873.
  • 22
    Michaëlsson M. Bilirubin determination in serum and urine: II. A compari-son of methods for the determination of serum bilirubin. Scandinav J Clin Lab Invest 1961; 13(suppl 56): 831.
  • 23
    Leach FR, Webster JJ. Commercially available firefly luciferase reagents. Methods Enzymol 1986; 133: 5170.
  • 24
    Higgins GM, Anderson RM. Experimental pathology of the liver: restora-tion of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186202.
  • 25
    Terada T, Nakanuma Y. Cell proliferative activity in adenomatous hyper-plasia of the liver and small hepatocellular carcinoma. Cancer 1992; 70: 591598.
  • 26
    Hofmann F, Wilkening J, Nowack J, Decker K. Response of isolated rat hepatocytes to D-galactosamine and uridine. Hoppe-Seyler's Z Physiol Chem 1976; 357: 427433.
  • 27
    Adibi SA, Paleos GA, Morse EL. Influence of molecular structure on half-life and hydrolysis of dipeptides in plasma: importance of glycine as N-terminal amino acid residue. Metabolism 1986; 35: 830836.
  • 28
    Souba WW, Smith RJ, Wilmore DW. Glutamine metabolism by the intesti-naltract. JPEN 1985; 9: 608617.
  • 29
    Record CO, Alberti KG. Glucose tolerance and blood metabolite changes in galactosamine hepatitis and obstructive jaundice in the rat. Eur J Clin Invest 1973; 3: 130135.
  • 30
    Nakatani T, Ozawa K, Asano M, Ukikusa M, Kamiyama Y, Tobe T. Differ-ences in predominant energy Substrate in relation to the resected hepatic mass in the phase immediately after hepatectomy. J Lab Clin Med 1981; 97: 887898.
  • 31
    Ozawa K. Hepatic function and liver resection. J Gastroenterol Hepatol 1990; 5: 296309.
  • 32
    Soni MG, Mehendale HM. Adenosine triphosphate protection of chlorde-cone-amplified CCl4 hepatotoxicity and lethality. J Hepatol 1994; 20: 267274.
  • 33
    Dajani OF, Refsnes M, Guren TK, Horn RS, Thoresen GH, Christoffersen T. Elevated glucose concentrations inhibit DNA synthesis and expression of c-myc in cultured hepatocytes. Biochem Biophys Res Commun 1994; 202: 14761482.
  • 34
    Chanda S, Mehendale HM. Nutritional impact on the final outcome of liver injury inflicted by model hepatotoxicants: effect of glucose loading. FASEB J 1995; 9: 240245.
  • 35
    Short J, Armstrong NB, Zemel R, Lieberman I. A role for amino acids in the induction of deoxyribonucleic acid synthesis in liver. Biochem Biophys Res Commun 1973; 50: 430437.
  • 36
    Nakamura T, Teramoto H, Tomita Y, Ichihara A. L-Proline is an essential amino acid for hepatocyte growth in culture. Biochem Biophys Res Commun 1984; 122: 884891.
  • 37
    Yoshida S, Yunoki T, Aoyagi K, Ohta J, Ishibashi N, Noake T, Kakegawa T. Effect of glutamine Supplement and hepatectomy on DNA and protein synthesis in the remnant liver. J Surg Res 1995; 59: 475481.
  • 38
    Tanaka T, Ando M, Yamashita T, Toda T, Monna T, Nishiguchi S, Matsui T, et al. Effects of alanine and glutamine administration on the Inhibition of liver regeneration by acute ethanol treatment. Alcohol Alcohol 1993; 28(suppl 1B ):4145.
  • 39
    Kaloyianni M, Freedland RA. Contribution of several amino acids and lactate to gluconeogenesis in hepatocytes isolated from rats fed various diets. J Nutr 1990; 120: 116122.
  • 40
    Mallette LE, Exton JH, Park CR. Control of gluconeogenesis from amino acids in the perfused rat liver. J Biol Chem 1969; 244: 57135723.
  • 41
    Klain GJ, Winders RL, Bonner SJ. Sequential changes in alanine metabolism following partial hepatectomy in the rat. J Nutr Biochem 1990; 1: 578584.
  • 42
    Pacitti AJ, Austgen TR, Souba WW. Adaptive regulation of alanine trans-port in hepatic plasma membrane vesicles from the endotoxin-treated rat. J Surg Res 1991; 51: 4653.
  • 43
    Le Cam A, Rey J-F, Fehlmann M, Kitabgi P, Freychet P. Amino acid transport in isolated hepatocytes after partial hepatectomy in the rat. Am J Physiol 1979; 236: E594E602.
  • 44
    Koch KS, Leffert HL. Increased sodium ion influx is necessary to initiate rat hepatocyte proliferation. Cell 1979; 18: 153163.